$2.85
+0.02 (+0.71%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,530.2% upside
Low Target
$33.82
Average Target
$46.46
High Target
$60.35
Current Price
$2.85
Current
$2.85
$2.85
Target
$46.46
$46.46
$33.82
$46.46 avg
$60.35
Scenario Analysis
Bear Case
$33.82
1,086.7%
Low target
Base Case
$46.46
+1,530.2%
Avg target
Bull Case
$60.35
+2,017.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.24
-11.9% from high
52-Week Low
$1.29
+120.9% from low
Target vs 52W High
$46.46
+1,336.2% vs high
Next Earnings Report
May 18, 2026 · Before Market Open
Today
EPS Est: $-0.07
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |